The class of drugs used by the UCLA team to block GABA receptors is currently in clinical development for other conditions, such as memory loss, and has been well-tolerated in small studies.
这类伽马氨基丁酸受体的抑制药物现正被加州大学的研究小组用于其他方面的临床研究,如失忆,并在一些小的研究上得到了广泛的认同。